EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure

This study has been completed.

Sponsor:

Information provided by:

Janssen Pharmaceutica N.V., Belgium

ClinicalTrials.gov Identifier:

NCT00338000

First received: June 16, 2006

Last updated: January 31, 2011

Last verified: January 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2005
Estimated Primary Completion Date:	No date given